The effects of antihypertensive agents on serum lipids and lipoproteins
- PMID: 2897834
The effects of antihypertensive agents on serum lipids and lipoproteins
Abstract
Hypertension is a major risk factor for arteriosclerotic vascular disease. Despite intensive antihypertensive intervention, the risk of cardiovascular disease has not declined appreciably. Many of the antihypertensive agents have been shown to elevate total serum cholesterol and triglyceride levels or lower the high-density lipoprotein-cholesterol level. Thus, the antihypertensive agents chosen may negate the beneficial effects of a lower blood pressure. Our purpose is to review all available antihypertensive medications and their influence on lipoprotein metabolism. Choosing the antihypertensive therapy least likely to worsen or precipitate other known cardiovascular risk factors is important. Cost and side effect profiles must also be considered in choosing the best antihypertensive regimen for your patients.
Similar articles
-
Serum lipoproteins during treatment with antihypertensive drugs.J Cardiovasc Pharmacol. 1993;22 Suppl 6:S98-105. J Cardiovasc Pharmacol. 1993. PMID: 7508069 Review.
-
[Recent trend in the research of hypertension in Japan. The effects of antihypertensive drugs on serum lipids and lipoproteins in patients with mild to moderate hypertension].Nihon Naika Gakkai Zasshi. 1988 Dec;77(12):1820-5. Nihon Naika Gakkai Zasshi. 1988. PMID: 2907996 Review. Japanese. No abstract available.
-
Effects of calcium antagonists and adrenergic antihypertensive drugs on plasma lipids and cellular cholesterol metabolism.J Cardiovasc Pharmacol. 1987;10 Suppl 10:S199-202. J Cardiovasc Pharmacol. 1987. PMID: 2455133 Review.
-
The choice of antihypertensive therapy in patients with the metabolic syndrome--time to change recommendations?Nephrol Dial Transplant. 2008 Nov;23(11):3389-91. doi: 10.1093/ndt/gfn455. Epub 2008 Aug 7. Nephrol Dial Transplant. 2008. PMID: 18687734 No abstract available.
-
[Effect of anti-hypertensive treatment on plasma lipids and lipoproteins (author's transl)].Pathol Biol (Paris). 1981 Sep;29(7):435-40. Pathol Biol (Paris). 1981. PMID: 6117048 French.
Cited by
-
A comparison of the haemodynamic and behavioural effects of moxonidine and clonidine in normotensive subjects.Br J Clin Pharmacol. 1992 Mar;33(3):261-7. doi: 10.1111/j.1365-2125.1992.tb04033.x. Br J Clin Pharmacol. 1992. PMID: 1576046 Free PMC article. Clinical Trial.
-
Clinical use of beta-adrenoceptor blockade in systemic hypertension.Drugs. 1990 Jun;39(6):862-76. doi: 10.2165/00003495-199039060-00005. Drugs. 1990. PMID: 1973382 Review.
-
Primary prevention potential of the calcium antagonists. Effects on blood pressure and lipid pattern.Drugs. 1992;43 Suppl 1:28-32. doi: 10.2165/00003495-199200431-00007. Drugs. 1992. PMID: 1378785 Review.
-
Decreased lipid levels in adult with congenital heart disease: a systematic review and Meta-analysis.BMC Cardiovasc Disord. 2023 Oct 27;23(1):523. doi: 10.1186/s12872-023-03455-w. BMC Cardiovasc Disord. 2023. PMID: 37891491 Free PMC article.
-
Antiatherogenic effects of calcium-channel blockers: possible mechanisms of action.Cardiovasc Drugs Ther. 1990 Aug;4 Suppl 5:1015-20. doi: 10.1007/BF02018310. Cardiovasc Drugs Ther. 1990. PMID: 2076387 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical